Bioventix

BVXP · LSE · Healthcare / Biotechnology

1,970.00GBX+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close1,970.00

Open1,975.00

Day Range1,955.00 – 2,000.00

52-Week Range1,251.47 – 2,319.15

Volume5.45K

Market Cap87.52M

P/E (TTM)11.88

Forward P/E23.15

EPS1.41

Dividend Yield8.96%

Beta0.56

50-Day Avg1,602.10

200-Day Avg1,653.65

About

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment. The company also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

Company Details

SectorHealthcare
IndustryBiotechnology
CEOMr. Peter John Harrison MA
Employees12
Headquarters7 Romans Business Park, Farnham, United Kingdom, GU9 7SX, UK
Websitehttps://www.bioventix.com

Leadership

Mr. Peter John Harrison MACEO & Director · b. 1958
Mr. Bruce Edward Heath HiscockCFO & Director · b. 1958

Financials

Income Statement

Currency: GBP	2011-06-30	2012-06-30	2013-06-30	2014-06-30	2015-06-30	2016-06-30	2017-06-30	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30
Total Revenue	1.97M	2.38M	2.71M	3.54M	4.33M	5.52M	7.25M	8.75M	9.29M	10.31M	10.93M	11.72M	12.82M	13.61M	13.12M
Growth (%)	-	+20.80%	+13.53%	+30.63%	+22.57%	+27.32%	+31.33%	+20.78%	+6.15%	+11.02%	+5.98%	+7.22%	+9.36%	+6.17%	-3.61%
Cost of Revenue	236.31K	203.58K	188.33K	302.87K	320.46K	494.88K	494.88K	573.20K	875.09K	955.39K	952.55K	853.84K	957.64K	925.53K	1.20M
Gross Profit	1.74M	2.18M	2.52M	3.23M	4.01M	5.02M	6.75M	8.18M	8.41M	9.36M	9.98M	10.87M	11.86M	12.68M	11.92M
Gross Margin	88.03%	91.46%	93.04%	91.43%	92.60%	91.03%	93.17%	93.45%	90.58%	90.74%	91.29%	92.71%	92.53%	93.20%	90.86%
Operating Expense	657.63K	685.54K	708.70K	860.97K	915.16K	892.46K	1.04M	1.27M	1.38M	1.40M	1.89M	1.59M	1.81M	2.08M	2.01M
Operating Income	1.08M	1.49M	1.81M	2.37M	3.10M	4.13M	5.71M	6.90M	7.03M	7.96M	8.09M	9.27M	10.04M	10.60M	9.90M
Operating Margin	54.70%	62.70%	66.86%	67.08%	71.48%	74.85%	78.81%	78.90%	75.68%	77.18%	73.99%	79.13%	78.38%	77.88%	75.51%
EBITDA	1.13M	1.55M	1.85M	2.40M	3.14M	4.17M	5.75M	6.96M	7.10M	8.11M	8.22M	9.42M	10.20M	10.74M	10.17M
EBITDA Margin	57.22%	65.00%	68.49%	67.96%	72.54%	75.61%	79.36%	79.57%	76.40%	78.68%	75.21%	80.40%	79.58%	78.93%	77.51%
Net Income	884.46K	1.24M	1.52M	1.82M	2.56M	3.49M	4.92M	5.66M	5.86M	7.20M	6.73M	7.67M	8.37M	8.10M	7.58M
Net Income Margin	44.82%	51.90%	56.22%	51.35%	59.02%	63.34%	67.93%	64.71%	63.10%	69.84%	61.58%	65.48%	65.33%	59.51%	57.83%
R&D	498.00K	454.00K	505.19K	552.50K	511.82K	713.72K	764.48K	868.51K	1.12M	1.18M	1.20M	975.32K	1.20M	999.42K	1.49M
R&D as % of Total Revenue	25.23%	19.04%	18.67%	15.63%	11.81%	12.94%	10.55%	9.92%	12.02%	11.40%	10.99%	8.32%	9.37%	7.35%	11.33%
Interest Expense	0	120	97	104	1.87K	164	0	15	0	243.74K	263.42K	303	0	-	-
Interest Expense % of Total Revenue	0.00%	0.01%	0.00%	0.00%	0.04%	0.00%	0.00%	0.00%	0.00%	2.36%	2.41%	0.00%	0.00%	-	-

Balance Sheet

Currency: GBP	2006-06-30	2007-06-30	2008-06-30	2009-06-30	2010-06-30	2011-06-30	2012-06-30	2013-06-30	2014-06-30	2015-06-30	2016-06-30	2017-06-30	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30

Currency: GBP	2006-06-30	2007-06-30	2008-06-30	2009-06-30	2010-06-30	2011-06-30	2012-06-30	2013-06-30	2014-06-30	2015-06-30	2016-06-30	2017-06-30	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30
Total Assets	1.03M	960.00K	1.41M	2.38M	2.55M	2.87M	3.55M	4.51M	5.77M	6.90M	8.78M	10.38M	11.88M	11.61M	13.30M	12.91M	13.12M	13.28M	13.73M	12.86M
Total Liabilities	1.10M	1.11M	1.19M	1.53M	181.00K	190.62K	213.54K	307.34K	530.91K	317.84K	567.86K	236.06K	864.66K	787.43K	778.87K	1.09M	1.30M	1.22M	1.73M	1.31M
Total Equity	-	-	212.00K	850.00K	2.37M	2.68M	3.34M	4.20M	5.24M	6.58M	8.21M	10.14M	11.01M	10.83M	12.52M	11.82M	11.82M	12.06M	12.00M	11.55M
Cash	206.00K	193.00K	413.00K	1.18M	1.35M	1.53M	2.18M	2.59M	3.35M	4.13M	5.38M	6.17M	6.99M	6.54M	8.08M	6.49M	6.13M	5.72M	6.00M	5.08M
Net Debt	-	-	-	-	-	-1.53M	-2.18M	-2.59M	-3.35M	-4.13M	-5.38M	-6.17M	-6.99M	-6.54M	-8.08M	-6.49M	-6.13M	-5.72M	-6.00M	-5.08M

Cash Flow

Currency: GBP	2011-06-30	2012-06-30	2013-06-30	2014-06-30	2015-06-30	2016-06-30	2017-06-30	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30
Operating Cash Flow	766.14K	1.24M	1.34M	1.77M	2.15M	3.17M	3.96M	5.92M	5.88M	7.72M	6.37M	7.56M	7.90M	8.34M	7.03M
Investing Cash Flow	-10.74K	-16.70K	-278.43K	-136.57K	-103.10K	2.58K	-118.36K	-169.38K	-146.84K	-561.28K	-259.83K	-11.76K	90.51K	186.06K	173.16K
Financing Cash Flow	-572.84K	-574.90K	-656.32K	-862.74K	-1.26M	-1.92M	-3.05M	-4.93M	-6.18M	-5.62M	-7.69M	-7.92M	-8.30M	-8.25M	-8.12M
Capital Expenditure	10.74K	16.70K	21.33K	1.91K	113.75K	21.01K	21.70K	107.59K	84.52K	339.62K	260.33K	11.76K	10.58K	15.91K	19.19K
Free Cash Flow	755.40K	1.22M	1.32M	1.76M	2.03M	3.15M	3.94M	5.81M	5.79M	7.38M	6.11M	7.55M	7.89M	8.33M	7.01M
Dividends Paid	524.12K	574.90K	656.32K	921.45K	1.28M	1.92M	3.37M	4.93M	6.22M	6.50M	7.71M	7.92M	8.44M	8.25M	8.19M
FCF to OCF	98.60%	98.65%	98.41%	99.89%	94.70%	99.34%	99.45%	98.18%	98.56%	95.60%	95.91%	99.84%	99.87%	99.81%	99.73%
Dividend Paid to FCF	69.38%	47.03%	49.73%	52.25%	63.11%	61.08%	85.72%	84.84%	107.39%	88.07%	126.23%	104.88%	106.97%	99.03%	116.86%

Earnings

Report Date	Oct 17, 2016	Mar 20, 2017	Oct 17, 2017	Mar 22, 2018	Oct 8, 2018	Mar 21, 2019	Oct 21, 2019	Mar 30, 2020	Oct 19, 2020	Mar 29, 2021	Oct 18, 2021	Mar 30, 2022	Oct 24, 2022	Mar 27, 2023	Mar 31, 2025	Nov 11, 2025
EPS Estimate	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-	0.00	0.78
EPS Actual	0.41	0.39	0.56	0.54	0.54	0.53	0.60	0.68	0.70	0.59	0.69	0.57	0.89	0.71	0.71	0.72
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-7.69%
Timing	-	-	-	-	-	-	-	-	-	-	-	-	After-hours	Pre-market	-	-

Key Statistics & Ratios

Market Cap87.52M

Enterprise Value75.68M

Trailing P/E11.88

Forward P/E23.15

Price / Sales6.98

Price / Book7.33

EPS1.41

Book Value2.11

Revenue (TTM)12.54M

Gross Profit (TTM)11.59M

EBITDA9.84M

Profit Margin59.30%

Operating Margin76.56%

Return on Equity66.64%

Return on Assets46.91%

Shares Outstanding5.22M

Shares Float4.15M

Beta0.56

Dividend Yield8.96%

Dividend Rate1.50

Payout Ratio2.08%

Dividends

20262×

0.80Nov 5, 20260.70Apr 9, 2026

20252×

0.80Nov 6, 20250.70Apr 10, 2025

20242×

0.87Nov 7, 20240.68Apr 11, 2024

20232×

0.90Nov 9, 20230.62Apr 6, 2023

20222×

1.00Nov 3, 20220.52Apr 7, 2022

20212×

1.00Oct 28, 20210.43Apr 8, 2021

20202×

1.05Oct 29, 20200.36Apr 9, 2020

20192×

0.90Oct 31, 20190.30Apr 11, 2019

20182×

0.91Oct 25, 20180.25Apr 5, 2018

20172×

0.71Oct 26, 20170.20Apr 6, 2017

20162×

0.46Oct 27, 20160.17Apr 7, 2016

20152×

0.22Oct 15, 20150.11Apr 9, 2015